• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Amendia

Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017

July 12, 2017 By Fink Densford

Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]

Filed Under: Business/Financial News Tagged With: Abiomed, Accuray Inc., Amendia, Boston Scientific, C.R. Bard, Cochlear Ltd., conformis, GE Healthcare, InVivo Corp., IsoRay, Johnson and Johnson, Lidco, Lumicell, Neurometrix, Philips, portal instruments, RenalGuard Solutions, Sanofi-Aventis, Spinal Elements, stjudemedical, Stryker, TherOx Inc, Zimmer Biomet

Amendia rebrands under acquired company moniker Spinal Elements

July 10, 2017 By Fink Densford

Amendia said today it is rebranding under the moniker Spinal Elements, the name of a company it acquired in April this year. The Marietta, Ga.-based company said the change “reflect’s the company’s dedication to developing novel medical device technologies, biologics and instrumentation to create positive surgical outcomes,” according to a press release. “We know surgeons want […]

Filed Under: Business/Financial News Tagged With: Amendia, Spinal Elements

Amendia picks up Spinal Elements

April 17, 2017 By Fink Densford

Amendia said last Friday it acquired Carlsbad, Calif.-based spinal device developer Spinal Elements for an undisclosed amount. Spinal Elements produces the Ti-Bond porous titanium coating designed for orthopedic devices, and has upcoming launches planned for its Lucent XP expandable cage and Clutch interspinous device. “The acquisition of Spinal Elements brings a wealth of talent and a […]

Filed Under: Mergers & Acquisitions, Spine Tagged With: Amendia, Spinal Elements

Nestle poaches Fresenius CEO Schneider | Personnel Moves for July 1, 2016

July 1, 2016 By Brad Perriello

Nestle poaches Fresenius CEO Schneider Nestle (VTX:NESN) lured the CEO of Fresenius (NYSE:FMS), Ulf Mark Schneider, to the corner office this week. Fresenius promoted CFO Stephan Sturm to replace Schneider. Read more

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News, Food & Drug Administration (FDA) Tagged With: Amendia, Conavi, FDA, Fresenius, Nestlé S.A., Nonin Medical Inc., Personnel Moves

Kohlberg picks up controlling stake in Amendia

May 3, 2016 By Fink Densford

Amendia said last week that private equity firm Kohlberg & Company inked a deal to snag a majority ownership in Amendia. Kohlberg & Company will support Amendia’s growth initiatives with its $1.6 billion private equity fund, the company said. “We are thrilled with our new partners and the resources they bring to the Amendia organization. […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Amendia

Amendia’s buying spree continues with Sinu-Lok licensing deal

September 16, 2015 By Fink Densford

Amendia is continuing its buying spree, saying today it purchased the rights to Sinu-Lok, a novel, minimally invasive rod implant replacement used in thoracolumbar spine surgery. The device was developed and patented by the Institute for Applied Neuroscience technology accelerator at Charleston, S.C.’s Medical University of South Carolina, according to Marietta, Ga.-based Amendia. “We are very […]

Filed Under: Business/Financial News, Implants, Mergers & Acquisitions, Spine Tagged With: Amendia

Amendia buys Custom Spine

July 31, 2015 By Fink Densford

Amendia said Tuesday it acquired New Jersey-based spinal technology company Custom Spine. Amendia did not disclose the details of the acquisition. Marietta, Ga.-based Amendia said the acquisition would further its focus on the spinal market and that Custom Spine’s Pathway articulating vertebral interbody technology was of specific interest to Amendia. “I’m looking forward to adding Custom […]

Filed Under: Mergers & Acquisitions, Spine Tagged With: Amendia

Amendia acquires SpineSelect assets

June 24, 2015 By Fink Densford

Amendia Inc. said yesterday that it acquired the minimally-invasive transforaminal lumbar interbody fusion system assets from SpineSelect. The system assets purchased by Amendia include 2 product families – the Marquise MIS channel system and the Turbo MIS TLIF system, the Marietta, Ga.-based company said. “The addition of SpineSelect’s MITLIF system allows Amendia to offer another superior […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Spine Tagged With: Amendia, SpineSelect

Medline nabs Amendia’s cervical spinal surgery tech in closed-doors deal

April 22, 2014 By Arezu Sarvestani Leave a Comment

Medline nabs Amendia's cervical spinal surgery tech in closed-doors deal

Illinois-based Medline Industries acquired key spine surgery technologies from Georgia-based Amendia, the companies announced this month.

Medline nabbed Amendia’s anterior cervical fusion distraction pin business, part of a market that Medline expects to grow more than 8% annually. The technologies are used in surgeries for removing problem disks in the neck area of the spine.

Filed Under: Mergers & Acquisitions, News Well, Spine, Surgical Tagged With: Amendia, Medline Industries Inc.

Boston Scientific’s CEO defends the troubled Guidant buyout | Wall Street Beat

May 8, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Boston Scientific’s (NYSE:BSX) interim CEO Hank Kucheman still believes in the company’s ill-fated acquisition of Guidant Corp., a deal worth $26 billion that was followed by recalls, lawsuits and criminal charges.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Abbott, Amendia, Boston Scientific, Cardiac Rhythm Management, Deals Roundup, Group Purchasing Organizations (GPO), Guidant Corp., Intuitive Surgical, MAKO Surgical Corp., Medline Industries Inc., Philips, Verisante Technology

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS